Journal
NUTRIENTS
Volume 11, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/nu11030605
Keywords
beta-cell; mTOR; insulin; pancreas; mouse; low-protein; glucagon; STING
Categories
Funding
- Canadian Institutes of Health Research [MOP-15263]
- Alan Thicke Centre for Juvenile Diabetes Research
- Program of Experimental Medicine [R0362A06]
- Department of Medicine, Schulich School of Medicine, Western University
- Norman Family Trust
- JDRF Career Development Award [5-CDA-2014-221-A-N]
- Diabetes UK [15/0005156]
Ask authors/readers for more resources
Low birth weight is a risk factor for gestational and type 2 diabetes (T2D). Since mammalian target of rapamycin (mTOR) controls pancreatic beta-cell mass and hormone release, we hypothesized that nutritional insult in utero might permanently alter mTOR signaling. Mice were fed a low-protein (LP, 8%) or control (C, 20%) diet throughout pregnancy, and offspring examined until 130 days age. Mice receiving LP were born 12% smaller and beta-cell mass was significantly reduced throughout life. Islet mTOR levels were lower in LP-exposed mice and localized predominantly to alpha-rather than beta-cells. Incubation of isolated mouse islets with rapamycin significantly reduced cell proliferation while increasing apoptosis. mRNA levels for mTORC complex genes mTOR, Rictor and Raptor were elevated at 7 days in LP mice, as were the mTOR and Raptor proteins. Proglucagon gene expression was similarly increased, but not insulin or the immune/metabolic defense protein STING. In human and mouse pancreas STING was strongly associated with islet beta-cells. Results support long-term changes in islet mTOR signaling in response to nutritional insult in utero, with altered expression of glucagon and insulin and a reduced beta-cell mass. This may contribute to an increased risk of gestational or type 2 diabetes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available